Levalbuterol Inhalation Solution is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Northstar Rxllc. The primary component is Levalbuterol Hydrochloride.
| Product ID | 16714-095_a60ea366-65a8-4559-9af5-5afd97875d2e |
| NDC | 16714-095 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Levalbuterol Inhalation Solution |
| Generic Name | Levalbuterol Inhalation Solution |
| Dosage Form | Solution |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2020-05-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207820 |
| Labeler Name | NorthStar RxLLC |
| Substance Name | LEVALBUTEROL HYDROCHLORIDE |
| Active Ingredient Strength | 1 mg/3mL |
| Pharm Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-05-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA207820 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-05 |
| Ingredient | Strength |
|---|---|
| LEVALBUTEROL HYDROCHLORIDE | .63 mg/3mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 16714-094 | Levalbuterol Inhalation Solution | Levalbuterol Inhalation Solution |
| 16714-095 | Levalbuterol Inhalation Solution | Levalbuterol Inhalation Solution |
| 16714-096 | Levalbuterol Inhalation Solution | Levalbuterol Inhalation Solution |
| 47335-743 | Levalbuterol Inhalation Solution | Levalbuterol Inhalation Solution |
| 47335-746 | Levalbuterol Inhalation Solution | Levalbuterol Inhalation Solution |
| 47335-753 | Levalbuterol Inhalation Solution | Levalbuterol Inhalation Solution |